Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-amino acids: versatile peptidomimetics.

David L Steer1, Rebecca A Lew, Patrick Perlmutter

  • 1Department of Biochemistry & Molecular Biology, Monash University, Monash, Vic 3800, Australia.

Current Medicinal Chemistry
|April 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure, Interactions, and Assembly of Membrane-Active Antimicrobial Polypeptides.

Chemical reviews·2026
Same author

An antagomiR-loaded β-peptide hydrogel promotes functional recovery in mice post-ischaemic stroke.

Biomaterials advances·2026
Same author

Accurate quantitation of antibiotic penetration through staphylococcal biofilms.

Biofilm·2025
Same author

Decoding the role of mycobacterial lipid remodelling and membrane dynamics in antibiotic tolerance.

Chemical science·2024
Same author

Gladiolin produced by pathogenic <i>Burkholderia</i> synergizes with amphotericin B through membrane lipid rearrangements.

mBio·2024
Same author

Structure of a Rhs effector clade domain provides mechanistic insights into type VI secretion system toxin delivery.

Nature communications·2024
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
Same journal

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Current medicinal chemistry·2026
Same journal

DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

Synthetic AtMP2 from Anabas testudineus: Comprehensive ADMET and In Vivo Toxicity Assessment to Enable Future Therapeutic Development.

Current medicinal chemistry·2026
Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026
See all related articles

Beta-amino acids are versatile building blocks for creating peptidomimetics, offering enhanced stability and biological activity. Their structural diversity makes them a promising platform for designing novel therapeutic peptides.

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Biotechnology

Background:

  • Peptides face limitations in therapeutic use due to poor physical characteristics.
  • Peptidomimetics offer a solution by mimicking peptide structures with improved properties.
  • Beta-amino acids represent a key strategy in peptidomimetic design.

Purpose of the Study:

  • To review the applications of beta-amino acids in designing bioactive peptide analogues.
  • To highlight the potential of beta-amino acids as a platform technology for peptidomimetics.

Main Methods:

  • Review of existing literature on beta-amino acid applications.
  • Analysis of structural diversity and synthesis of beta-amino acids.
  • Examination of incorporation into peptide sequences via solid-phase synthesis.

Related Experiment Videos

Main Results:

  • Beta-amino acids possess unique structural features (e.g., diastereoisomers) enabling extensive molecular design.
  • Incorporation of beta-amino acids yields peptidomimetics with potent biological activity and resistance to proteolysis.
  • Applications span receptor agonists/antagonists, MHC-binding peptides, antimicrobials, and enzyme inhibitors.

Conclusions:

  • Beta-amino acids offer significant structural diversity and synthetic accessibility.
  • They represent a powerful platform technology for developing novel peptidomimetics with therapeutic potential.